Displaying drugs 14351 - 14375 of 14649 in total
Dipipanone
Experimental
Illicit
Balanol Analog 2
Experimental
N-[3-(aminomethyl)benzyl]acetamidine
Experimental
Diethyl 4-Methylbenzylphosphonate
Experimental
Iodobenzene
Experimental
ES-936
Experimental
AL7182
Experimental
S-Ethyl-N-[4-(Trifluoromethyl)Phenyl]Isothiourea
Experimental
4-(2-Thienyl)-1-(4-Methylbenzyl)-1h-Imidazole
Experimental
PAS219
Experimental
Phenacetin
Phenacetin was withdrawn from the Canadian market in June 1973 due to concerns regarding nephropathy (damage to or disease of the kidney).
Withdrawn
1,3,5-trichlorobenzene
Experimental
(P-Iodophenylacetylamino)Methylphosphinic Acid
Experimental
1-(4-Amidinophenyl)-3-(4-Chlorophenyl)Urea
Experimental
N-(Chlorophenyl)-N'-hydroxyguanidine
Experimental
(R)-4-Nitrostyrene oxide
Experimental
SC45647
Experimental
Cannabinor
Cannabinor, a synthetic CB2-selective agonist, is in Phase 2 clinical testing as an analgesic.
Investigational
Indisulam
Investigational
Displaying drugs 14351 - 14375 of 14649 in total